Expression proteomics study to determine metallodrug targets and optimal drug combinations
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Expression proteomics study to determine metallodrug targets and optimal drug combinations ; volume:7 ; number:1 ; day:8 ; month:5 ; year:2017 ; pages:1-11 ; date:12.2017
Scientific reports ; 7, Heft 1 (8.5.2017), 1-11, 12.2017
- Creator
-
Lee, Ronald F. S.
Chernobrovkin, Alexey
Rutishauser, Dorothea
Allardyce, Claire S.
Hacker, David
Johnsson, Kai
Zubarev, Roman A.
Dyson, Paul J.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-017-01643-1
- URN
-
urn:nbn:de:101:1-2019080921302455310206
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.01.2025, 6:25 AM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lee, Ronald F. S.
- Chernobrovkin, Alexey
- Rutishauser, Dorothea
- Allardyce, Claire S.
- Hacker, David
- Johnsson, Kai
- Zubarev, Roman A.
- Dyson, Paul J.
- SpringerLink (Online service)
Other Objects (12)
Optimal drug combinations and minimal hitting sets
Rational combinations of immunotherapeutics that target discrete pathways
Optimal Portfolio Choice Under Decision-Based Model Combinations
Screening drug target combinations in disease-related molecular networks
Optimal Combinations of Income Tax and Subsidies for Education
Synergistic Target Combinations Against Obesity: Focus on MCHR1/H3R Modulation
Exploring optimal drug targets through subtractive proteomics analysis and pangenomic insights for tailored drug design in tuberculosis
The Scottish Structural Proteomics Facility: targets, methods and outputs
Proteomics of AML1/ETO Target Proteins: AML1–ETO Targets a C/EBP–NM23 Pathway
Chemical proteomics strategies for elucidation of cellular steroid hormone targets
Chemical Proteomics Reveals the Target Landscape of Clinical Kinase Inhibitors.
Combinations-Linien.
Optimal drug combinations and minimal hitting sets
Rational combinations of immunotherapeutics that target discrete pathways
Optimal Portfolio Choice Under Decision-Based Model Combinations
Screening drug target combinations in disease-related molecular networks
Optimal Combinations of Income Tax and Subsidies for Education
Synergistic Target Combinations Against Obesity: Focus on MCHR1/H3R Modulation
Exploring optimal drug targets through subtractive proteomics analysis and pangenomic insights for tailored drug design in tuberculosis
The Scottish Structural Proteomics Facility: targets, methods and outputs
Proteomics of AML1/ETO Target Proteins: AML1–ETO Targets a C/EBP–NM23 Pathway
Chemical proteomics strategies for elucidation of cellular steroid hormone targets
Chemical Proteomics Reveals the Target Landscape of Clinical Kinase Inhibitors.
Combinations-Linien.
Optimal drug combinations and minimal hitting sets
Rational combinations of immunotherapeutics that target discrete pathways
Optimal Portfolio Choice Under Decision-Based Model Combinations
Screening drug target combinations in disease-related molecular networks
Optimal Combinations of Income Tax and Subsidies for Education
Synergistic Target Combinations Against Obesity: Focus on MCHR1/H3R Modulation
Exploring optimal drug targets through subtractive proteomics analysis and pangenomic insights for tailored drug design in tuberculosis
The Scottish Structural Proteomics Facility: targets, methods and outputs
Proteomics of AML1/ETO Target Proteins: AML1–ETO Targets a C/EBP–NM23 Pathway
Chemical proteomics strategies for elucidation of cellular steroid hormone targets
Chemical Proteomics Reveals the Target Landscape of Clinical Kinase Inhibitors.